CRISPR Medicine News

At CRISPR Medicine News we focus on topics related to gene editing and gene therapy using CRISPR (or similar tools) for the treatment of human diseases. We strive to bring the best and most interesting interviews and news on everything related to this exciting and rapidly emerging field. We write about CRISPR – the reagents, delivery methods, safety, quality control, clinical trials, standards and best practices, including in-depth interviews with researchers and specialists in academia, pharma companies and regulatory units working with CRISPR within the human disease field. Besides CRISPR, you will also meet the other genome-editing tools, such as base editors, prime editors, zinc finger nucleases, TALENs and MegaNucleases and other new genome editors as they emerge.

,
Founded in 2019
11-50 employees

At CRISPR Medicine News we focus on topics related to gene editing and gene therapy using CRISPR (or similar tools) for the treatment of human diseases. We strive to bring the best and most interesting interviews and news on everything related to this exciting and rapidly emerging field. We write about CRISPR – the reagents, delivery methods, safety, quality control, clinical trials, standards and best practices, including in-depth interviews with researchers and specialists in academia, pharma companies and regulatory units working with CRISPR within the human disease field. Besides CRISPR, you will also meet the other genome-editing tools, such as base editors, prime editors, zinc finger nucleases, TALENs and MegaNucleases and other new genome editors as they emerge.

Company Information

Industry
Company Type
Privately Held
Founded
2019
Employee Range
11-50
Revenue Range
Not available

Location

Address
Kong Georgs Vej 12 Frederiksberg
City
Region
Postal Code
2000
Country
Denmark

Web Presence

Ready to automate your outreach?

Get unlimited access to our company database — complete with detailed profiles, funding info, and tech stacks — and start sending personalized emails with AI-powered follow-ups.

Frequently Asked Questions